Wolfgang Miesbach: Exceptional Presentation on the Role of vWF in Angiogenesis and Gut Angiodysplasia in VWD
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on LinkedIn:
“Outstanding science at EAHAD 2026 in Dublin!
One of the highlights of this year’s congress was the exceptional presentation by Anna Randi on the fascinating — and still underappreciated — role of Von Willebrand Factor in angiogenesis and gut angiodysplasia in VWD, why VWF replacement therapy fails in GI bleeding — and what we can do about it.
The clinical problem: 5–20% of VWD patients suffer recurrent, intractable GI bleeding from angiodysplasia — dilated, fragile mucosal vessels prone to rupture.
VWF/FVIII concentrates reduce joint bleeds effectively, but annualised GI bleed rates remain stubbornly high (median 6 episodes/year even on prophylaxis, VWD-PN data).
Beyond the gut: Vascular abnormalities in VWD are not restricted to the GI tract. A scoping review of 61 studies and 146 patients confirmed malformations also in the mouth and face, skin, spleen, brain (AVMs), and genitourinary tract — with 15 patients documented as having HHT. All subtypes are affected, most frequently type 2A, 2B, and type 3.
The mechanism: VWF is not just a haemostatic protein — it is essential for forming Weibel-Palade Bodies (WPB) in endothelial cells. WPBs store Angiopoietin-2 (Angpt-2); without VWF, Angpt-2 leaks out continuously, disrupting the Angpt-1/Angpt-2 balance at the TIE2 receptor, driving pathological sprouting angiogenesis, vascular permeability, and inflammation.
The evidence: VWF-deficient ECs show increased tube formation, increased migration (reversed by VEGFR-2 inhibitor SU4312), and increased Angpt-2 secretion — confirmed in Matrigel, zebrafish models, and human colon tissue.”
Other posts featuring Wolfgang Miesbach on Hemostasis Today.
-
Apr 14, 2026, 13:01Shahzaib Maqbool: Preeclampsia Through a Hematology Lens
-
Apr 14, 2026, 12:46Rosa Hart: Inside Pediatric Stroke Recovery with Dr. Catherine Schuster
-
Apr 14, 2026, 12:39Gonzalo Ladreda: Innovation in Stroke Care Is About Timing, Integration, and Real-World Usability
-
Apr 14, 2026, 12:30Roy P.C. Kessels: Stroke’s Cognitive Impact on Young Adults Is Significant and Often Overlooked
-
Apr 14, 2026, 12:22Mehari Gebreyohanns: New Insights on Wake-Up Strokes from Emergency Settings in Texas and Louisiana
-
Apr 14, 2026, 12:08Enrico Ferro: Comparative Study Raises Questions on PFA Safety in AF at EHRA 2026
-
Apr 14, 2026, 11:39Prachi Patel: How B Vitamins and Large-Scale Research Are Shaping Stroke Prevention
-
Apr 14, 2026, 11:28Jamie Brannigan: Help Shape the Future of Brain-Computer Interfaces in Stroke and Neurological Care
-
Apr 14, 2026, 11:18David Ferri: A Fontan Conduit Thrombosis Managed With an Innovative Catheter-Based Thrombectomy